OMDA

Omada HealthNASDAQHealthcare

$12.58-0.24%ClosedMarket Cap: $741.3M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-12	JP Morgan	—	Overweight	—
2026-03-06	Barclays	—	Overweight	—
2026-03-06	Morgan Stanley	—	Overweight	—
2026-03-06	Canaccord Genuity	—	Buy	—
2026-03-06	BMO Capital	—	Outperform	—
2026-01-22	Needham	—	Buy	—
2026-01-05	Barclays	—	Overweight	—
2025-11-07	Needham	—	Buy	—
2025-11-07	Evercore ISI Group	—	Outperform	—
2025-11-07	Barclays	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Wed Dec 31	$-0.03	$253.9M	4
Thu Dec 31	$-0.10	$318.9M	4
Fri Dec 31	$-0.02	$383.1M	3
Sun Dec 31	$0.52	$453.3M	1